Original Research Article| Volume 114, P67-73, October 2022

Download started.


Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study



      We aimed to obtain evidence about the safety, acceptability, and feasibility of a direct-to-patient telemedicine medical abortion service in Mexico's private health sector.

      Study Design

      A prospective observational one-group study to evaluate a telemedicine abortion service, referred to as TeleAborto, was conducted at three private clinics and one nonclinician community-based provider. Information about the study was provided by phone, websites, and social media. Abortion seekers were screened for eligibility and underwent any pre-abortion tests requested by the study site at services close to home. Eligible participants received packages with abortion medication, analgesics, and instructions and a remote follow-up contact was scheduled for 7 to 14 days later. Primary outcomes include abortion outcome, management of adverse events, acceptability, and feasibility measures such as package reception and follow-up contact, and challenges to get pre- and post-abortion tests.


      We conducted 581 screenings and sent 378 study packages, all successfully received, reaching abortion seekers in all 32 states. All participants took medications before 70 days gestational age as per study protocol. Abortion outcome was determined for 87% of participants (330/378); 93% (306/330) had a successful abortion without intervention and 18 with intervention; 6 individuals decided to continue the pregnancy. Participants reported high satisfaction with TeleAborto, citing convenience as their most valued aspect (85%; 264/311).


      This study showed that guided self-managed telemedicine abortion is safe, acceptable, and feasible in Mexico. The model has the potential to close the access gap for indigenous and rural populations, and those that rely on public sector services.


      The findings contribute evidence in support of telemedicine models for early medical abortion, demonstrating the feasibility of a self-management protocol implemented with supportive health care providers and the potential for a broad geographical reach in Mexico.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Centro Nacional de Equidad de Género y Salud Reproductiva (CNEGSR), Secretaría de Salud, Gobierno de México. Lineamiento Técnico para la atención del Aborto Seguro en México [Internet]. 2021 [cited 2021 Oct 18]. Available from:

        • Küng SA
        • Wilkins JD
        • De León FD
        • Huaraz F
        • Pearson E.
        “We don't want problems”: reasons for denial of legal abortion based on conscientious objection in Mexico and Bolivia.
        Reprod Health. 2021; 18: 44
        • Schiavon R
        • Troncoso E.
        Inequalities in access to and quality of abortion services in Mexico: can task-sharing be an opportunity to increase legal and safe abortion care?.
        Int J Gynaecol Obstet. 2020; 150: 25-33
      2. Gobierno de la Ciudad de México, Secretaría de Salud. Interrupción Legal del Embarazo (ILE) Estadísticas abril 2007 - 30 de septiembre 2021 Sistema de Información de Interrupción Legal del Embarazo [Internet]. 2021 [cited 2021Oct 25]. Available from:

        • Nanda K
        • Lebetkin E
        • Steiner MJ
        • Yacobson I
        • Dorflinger LJ.
        Contraception in the Era of COVID-19.
        Glob Health Sci Pract. 2020; 8: 2
        • DeNicola N
        • Grossman D
        • Marko K
        • Sonalkar S
        • Tobah Y
        • Ganju N
        • et al.
        Telehealth interventions to improve obstetric and gynecologic health outcomes: a systematic review.
        Obstet Gynecol. 2020; 135: 371-382
        • Drovetta RI.
        Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
        Reprod Health Matters. 2015; 23: 47-57
        • Veldhuis S
        • Sanchez-Ramirez G
        • Darney BG.
        Becoming the woman she wishes to be”: a qualitative study exploring the experiences of medication abortion acompañantes in three regions in Mexico.
        Contracept. 2022; 106: 39-44
        • Guevara MVLD
        • Ilozumba O
        • Brandell KR
        • Gemzell-Danielsson K
        • Gomperts R.
        Reasons for using telemedicine medical abortion in Mexico and Chile.
        BMJ Sex Reprod Health. 2021; (Published online first)
      3. World Health Organization (WHO). WHO Guideline on self-care interventions for health and well-being [Internet]. 2021 [cited 2021 Oct 18]. Available from:

        • World Health Organization (WHO)
        Abortion care guideline.
        Geneva, 2022 (Licence: CC BY-NC-SA 3.0 IGO)
      4. American College of Obstetricians and Gynecologists (ACOG). Implementing telehealth in practice [Internet]. 2020 [cited 2021 Oct 18]. Available from:

      5. International Federation of Gynaecology and Obstetrics (FIGO). FIGO endorses the permanent adoption of telemedicine abortion services [Internet]. 2021 March [cited 2021 Oct 18]. Available from:

      6. Royal College of Obstetricians & Gynaecologists. (RCOG). Telemedical abortion care: Safeguarding young people statement from the Royal College of Obstetricians & Gynaecologists (RCOG) and the British Society of Abortion Care Providers (BSACP) regarding the advent of telemedical abortion care and the safeguarding of young people [Internet]. 2021 [cited 2021 Oct 18]. Available from:

        • Grossman D
        • Grindlay K.
        Safety of medical abortion provided through telemedicine compared with in person.
        Obstet Gynecol. 2017; 130: 778-782
        • Endler M
        • Lavelanet A
        • Cleeve A
        • Ganatra B
        • Gomperts R
        • Gemzell-Danielsson K.
        Telemedicine for medical abortion: a systematic review.
        BJOG. 2019; 126: 1094-1102
        • Raymond E
        • Chong E
        • Winikoff B
        • Platais I
        • Mary M
        • Lotarevich T
        • et al.
        TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
        Contracept. 2019; 100: 173-177
        • Fix L
        • Seymour JW
        • Vaid Sandhu M
        • Melville C
        • Mazza D
        • Thompson TA
        At-home telemedicine for medical abortion in Australia: a qualitative study of patient experiences and recommendations.
        BMJ Sex Reprod Health. 2020; 46: 159-160
        • Raymond EG
        • Grossman D
        • Mark A
        • Upadhyay UD
        • Dean G
        • Creinin MD
        • et al.
        No-test medication abortion: a sample protocol for increasing access during a pandemic and beyond.
        Contracept. 2020; 101: 361-366
        • Aiken ARA
        • Lohr PA
        • Lord J
        • Ghosh N
        • Starling J.
        Effectiveness, safety, and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.
        BJOG. 2021; 128: 1464-1474
        • Barney A
        • Buckelew S
        • Mesheriakova V
        • Raymond-Flesch M.
        The COVID-19 pandemic and rapid implementation of adolescent and young adult telemedicine: challenges and opportunities for innovation.
        J Adolesc Health. 2020; 67: 164-171
      7. Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and abortion care [Internet]. 2020 [cited 2021 Oct 18]. Available from:

        • Smith WR
        • Atala AJ
        • Terlecki RP
        • Kelly EE
        • Matthews CA.
        Implementation guide for rapid integration of an outpatient telemedicine program during the COVID-19 pandemic.
        J Am Coll Surg. 2020; 231: 216-222
      8. Centro Nacional de Excelencia Tecnológica en Salud (CENETEC). Acciones de telesalud en México [Internet]. 2020 [cited 2021 Oct 18]. Available from:

        • Carrera Riva-Palacio AG
        • Alvarez Tezpa AP
        • Carrera Hernandez MP
        • Oyamburu Viejo S
        • Hernandez Zarco GA
        • Moreno Ramirez H
        • et al.
        Telemedicine abortion during the COVID pandemic in Mexico City.
        Contracept. 2022; 109: 85
        • Porter Erlank C
        • Lord J
        • Church K.
        Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes.
        BMJ Sex Reprod Health. 2021; 47: 261-268
        • Grindlay K
        • Wollum A
        • Karver J
        • Grossman D.
        Over-the-counter oral contraceptive use among women in Mexico: results from a national survey.
        BMJ Sex Reprod Health. 2021; 47: 205-210
        • Saavedra-Avendano B
        • Schiavon R
        • Sanhueza P
        • Rios-Polanco R
        • Garcia-Martinez L
        • Darney BG.
        Early termination of pregnancy: differences in gestational age estimation using last menstrual period and ultrasound in Mexico.
        Reprod Health. 2020; 17: 89
        • Chong E
        • Shochet T
        • Raymond E
        • Thompson F
        • Priegue E
        • Winikoff B
        • et al.
        Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
        Contracept. 2021; 104: 43-48